Advertisement
UK markets open in 1 hour 14 minutes

  • NIKKEI 225

    38,413.04
    +860.88 (+2.29%)
     

  • HANG SENG

    17,161.27
    +332.34 (+1.97%)
     

  • CRUDE OIL

    83.52
    +0.16 (+0.19%)
     

  • GOLD FUTURES

    2,341.40
    -0.70 (-0.03%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,586.38
    +136.03 (+0.25%)
     

  • CMC Crypto 200

    1,439.95
    +25.19 (+1.78%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

$1.18 Bn RTF/RTU Vials Markets - Global Industry Analysis and Demand Forecast to 2030

Research and Markets
·4-min read

Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "RTF/RTU Vials Market Research Report 2021 - Global Industry Analysis and Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The revenue generated from the sale of RTF/RTU vials products will witness a 14.5% CAGR during 2021-2030, to reach $1,183.4 million by 2030.

The global ready-to-fill/ready-to-use (RTF/RTU) vials market is growing on account of the rising focus of pharmaceutical companies on higher operational efficiency, increasing popularity of injectable medicines, surging vial production output, escalating healthcare spending, and expanding pharmaceutical sector.

During the COVID-19 pandemic, the RTF/RTU vials market has received a boost due to the burgeoning demand for vaccines. Moreover, research and development (R&D) and clinical trial activities have surged during the pandemic, which has encouraged vial manufacturers to augment their output. As the efficient distribution of vaccines requires robust packaging, the vial demand is quite high presently.

Tray and nest & tub are the bifurcations of the RTF/RTU vials market on the basis of packaging type. Of these, nest and tub will be the larger share holder throughout the forecast period. Because this type of packaging emerged first, it has been more popular in the pharmaceutical sector. Additionally, with its nest-like arrangement, it reduces the chances of breakage and scratches, thereby improving the rate of vial acceptance among end users.

Europe will likely be the most-productive RTF/RTU vials market till 2030 due to the rising vial production output, growing pharmaceutical sector, and escalating healthcare expenditure. Additionally, numerous market players exist in the region, including SCHOTT AG, Stevanato Group, Gerresheimer AG, and SGD S.A., who are strongly focused on meeting the rising demand for COVID-19 vaccines.

In order to augment their revenue, players in the RTF/RTU vials market are expanding their facilities. For instance, in December 2020, a new pharmaceutical tubing factory was established by SCHOTT AG in Zhejiang Province, China. The factory will be used for producing 20,000 tons of FIOLAX borosilicate glass tubing for cartridges, vials, ampoules, and syringes, with the production output raised gradually.

In July 2020, plans to triple the production of tubular glass and double the manufacturing output of molded vials by the end of 2020 were announced by Gerresheimer India. After the expansion, the company aims to double its production of multi-dose borosilicate vials from 150 million units to 300 million units by 2021-end.

The most-prominent companies in the global RTF/RTU vials market are SCHOTT AG, SGD S.A., Gerresheimer AG, Stevanato Group, China Lemon Trading Co. Ltd., Nipro Corporation, DWK Life Sciences GmbH, and Ningbo Zhengli Pharmaceutical Packaging Co. Ltd.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Packaging Type
4.1.1.1 Nest and tub
4.1.1.2 Tray
4.1.2 By Color
4.1.2.1 Clear
4.1.2.2 Amber
4.1.3 By Placing Method
4.1.3.1 Side-up inside
4.1.3.2 Down-upside inside
4.1.4 By Filling Product
4.1.4.1 Liquid
4.1.4.2 Lyophilized
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Preference for personalized medicines and biologic drugs
4.2.2 Drivers
4.2.2.1 Need of pharmaceutical companies to increase their operational efficiency
4.2.2.2 Growing usage of injectable drugs
4.2.2.3 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Elimination of need for vials with prefilled syringes
4.2.3.2 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Increasing demand for RTU vaccine packaging
4.3 Porter's Five Forces Analysis
4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast
5.1 Overview
5.2 By Packaging Type
5.3 By Color
5.4 By Placing Method
5.5 By Filling Product
5.6 By Region

Chapter 6. Europe Market Size and Forecast

Chapter 7. North America Market Size and Forecast

Chapter 8. APAC Market Size and Forecast

Chapter 9. LATAM Market Size and Forecast

Chapter 10. MEA Market Size and Forecast

Chapter 11. Competitive Landscape
11.1 Recent Strategic Developments of Players
11.2 Market Share Analysis of Key Players
11.3 List of Market Players and Their Offerings
11.4 List of Customers and Potential Customers of RTF/RTU Vials

Chapter 12. Company Profiles
12.1 Business Overview
12.2 Product and Service Offerings

  • SGD Pharma

  • Stevanato Group

  • SCHOTT AG

  • Gerresheimer AG

  • Nipro Corporation

  • China Lemon Trading Co. Ltd.

  • Ningbo Zhengli Pharmaceutical Packaging Co. Ltd.

  • DWK Life Sciences GmbH

ADVERTISEMENT

For more information about this report visit https://www.researchandmarkets.com/r/4fraj2

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900